Track: Dermato Oncology
Dermato-Oncology looks at the fast-changing field of skin cancer prevention, diagnosis, treatment, and ongoing care for patients. The session includes topics like melanoma, non-melanoma skin cancers, cutaneous lymphomas, and rare skin tumors. It focuses on early detection, advanced imaging, surgical methods, and innovative treatments. Experts will talk about immunotherapy, targeted therapies, precision oncology, team-based care, and new treatment strategies that are changing how skin cancer is managed today.
Key Discussion Areas
- Melanoma Diagnosis and Management
- Advanced and Metastatic Melanoma
- Basal Cell Carcinoma and Squamous Cell Carcinoma
- Actinic Keratosis and Cutaneous Precancerous Lesions
- Cutaneous Lymphoma and Rare Skin Tumors
- Dermoscopy and Advanced Skin Cancer Imaging
- AI-Assisted Skin Cancer Detection
- Skin Biopsy, Histopathology and Diagnostic Evaluation
- Mohs Surgery and Other Surgical Treatments
- Immunotherapy for Advanced Skin Cancers
- Targeted and Molecular Therapies
- Precision and Personalized Oncology
- Biomarkers and Molecular Testing
- Neoadjuvant and Adjuvant Therapies
- Treatment-Resistant and Refractory Skin Cancers
- Multidisciplinary Skin Cancer Care
- Skin Cancer Prevention and Early Detection
- Emerging Therapies and Clinical Trials
Importance of the Session
This session covers a key area in modern dermatology by bringing together dermatologists, oncologists, surgeons, researchers, and industry professionals to talk about new ways to detect and treat skin cancer. It also offers great opportunities for companies in the pharmaceutical, biotech, diagnostics, medical imaging, and medical devices fields that make products for immunotherapy, targeted therapies, molecular testing, and skin cancer treatments.
Who Should Attend?
This session is for dermatologists, dermatopathologists, medical and surgical oncologists, plastic surgeons, researchers, academics, healthcare professionals, pharmaceutical and biotech experts, diagnostic specialists, medical device professionals, and industry leaders interested in new developments in skin cancer and dermato-oncology. Participants are invited to share their latest research, clinical experiences, innovative tools, and new treatments with an international audience. Researchers, doctors, and industry professionals are encouraged to submit their abstracts and help create the scientific program.8. Pediatric Dermatology